Metoclopramide-induced Parkinsonism

K. D. Sethi, B. Patel, K. J. Meador

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Metoclopramide hydrochloride (Reglan) is a widely prescribed drug for treatment of upper gastrointestinal symptoms. Although the drug is relatively safe, a growing body of literature has noted movement disorders after its administration. We have reported six cases of metoclopramide-induced parkinsonism seen in consultation over a two-year period. Five of these six patients had renal failure. Their parkinsonism improved on discontinuation of metoclopramide therapy. Metoclopramide-induced parkinonism is not rare, and appropriate dose reduction in patients with renal failure will help reduce the incidence of this morbidity.

Original languageEnglish (US)
Pages (from-to)1581-1582
Number of pages2
JournalSouthern Medical Journal
Volume82
Issue number12
DOIs
StatePublished - Jan 1 1989

Fingerprint

Metoclopramide
Parkinsonian Disorders
Renal Insufficiency
Movement Disorders
Pharmaceutical Preparations
Referral and Consultation
Morbidity
Incidence
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sethi, K. D., Patel, B., & Meador, K. J. (1989). Metoclopramide-induced Parkinsonism. Southern Medical Journal, 82(12), 1581-1582. https://doi.org/10.1097/00007611-198912000-00033

Metoclopramide-induced Parkinsonism. / Sethi, K. D.; Patel, B.; Meador, K. J.

In: Southern Medical Journal, Vol. 82, No. 12, 01.01.1989, p. 1581-1582.

Research output: Contribution to journalArticle

Sethi, KD, Patel, B & Meador, KJ 1989, 'Metoclopramide-induced Parkinsonism', Southern Medical Journal, vol. 82, no. 12, pp. 1581-1582. https://doi.org/10.1097/00007611-198912000-00033
Sethi, K. D. ; Patel, B. ; Meador, K. J. / Metoclopramide-induced Parkinsonism. In: Southern Medical Journal. 1989 ; Vol. 82, No. 12. pp. 1581-1582.
@article{40b6cec95cb742d7ae5beb93bf74ba1a,
title = "Metoclopramide-induced Parkinsonism",
abstract = "Metoclopramide hydrochloride (Reglan) is a widely prescribed drug for treatment of upper gastrointestinal symptoms. Although the drug is relatively safe, a growing body of literature has noted movement disorders after its administration. We have reported six cases of metoclopramide-induced parkinsonism seen in consultation over a two-year period. Five of these six patients had renal failure. Their parkinsonism improved on discontinuation of metoclopramide therapy. Metoclopramide-induced parkinonism is not rare, and appropriate dose reduction in patients with renal failure will help reduce the incidence of this morbidity.",
author = "Sethi, {K. D.} and B. Patel and Meador, {K. J.}",
year = "1989",
month = "1",
day = "1",
doi = "10.1097/00007611-198912000-00033",
language = "English (US)",
volume = "82",
pages = "1581--1582",
journal = "Southern Medical Journal",
issn = "0038-4348",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Metoclopramide-induced Parkinsonism

AU - Sethi, K. D.

AU - Patel, B.

AU - Meador, K. J.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Metoclopramide hydrochloride (Reglan) is a widely prescribed drug for treatment of upper gastrointestinal symptoms. Although the drug is relatively safe, a growing body of literature has noted movement disorders after its administration. We have reported six cases of metoclopramide-induced parkinsonism seen in consultation over a two-year period. Five of these six patients had renal failure. Their parkinsonism improved on discontinuation of metoclopramide therapy. Metoclopramide-induced parkinonism is not rare, and appropriate dose reduction in patients with renal failure will help reduce the incidence of this morbidity.

AB - Metoclopramide hydrochloride (Reglan) is a widely prescribed drug for treatment of upper gastrointestinal symptoms. Although the drug is relatively safe, a growing body of literature has noted movement disorders after its administration. We have reported six cases of metoclopramide-induced parkinsonism seen in consultation over a two-year period. Five of these six patients had renal failure. Their parkinsonism improved on discontinuation of metoclopramide therapy. Metoclopramide-induced parkinonism is not rare, and appropriate dose reduction in patients with renal failure will help reduce the incidence of this morbidity.

UR - http://www.scopus.com/inward/record.url?scp=0024852078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024852078&partnerID=8YFLogxK

U2 - 10.1097/00007611-198912000-00033

DO - 10.1097/00007611-198912000-00033

M3 - Article

VL - 82

SP - 1581

EP - 1582

JO - Southern Medical Journal

JF - Southern Medical Journal

SN - 0038-4348

IS - 12

ER -